Recent Stories
WoundGenex and Shoreline Medical Administration Form Strategic Alliance to Deliver Bundled Revenue Cycle Solutions with Clawback Protection
WoundGenex and Shoreline Medical Administration Form Strategic Alliance to Deliver Bundled Revenue Cycle Solutions with Clawback Protection TAMPA, Fla., Sept. 2, 2025 /PRNewswire/ — WoundGenex, the industry leader in wound care revenue
The LCD Delay — Victory or Wake-Up Call?
On the surface, the recent delay of the new Medicare LCD for skin substitutes to January 2026 may appear to be a win for providers and patients alike. After all,
Understanding the Impact of RCM on Patient and Provider Outcomes
Explore the impact of revenue cycle management on healthcare stability and patient experience through effective strategies.
The Growing Challenge of Patient Payment Delays
Patient payment delays are rising due to high-deductible health plans and recent policy changes. Learn how to optimize collections, reduce non-payments, and stay compliant with expert RCM solutions from WoundGenex
Key Lessons from the 2025 LCD Commenting Period
The 2025 LCD for skin substitutes brought transformative updates for DFUs and VLUs, shaped by stakeholder input and evidence-based policies. Key changes include measurable healing criteria, extended treatment durations, and
How Pre-Authorization Enhances Patient Care While Ensuring HIPAA Compliance
Get to know the ins and outs of pre-authorization and how it can improve the efficiency and security of your payment procedures.
Most Popular Stories
WoundGenex Partners with MiMedx to Launch Premier Graft Program to Wound Care Providers Nationwide
WoundGenex Partners with MiMedx to Launch Premier Graft Program to Wound Care Providers Nationwide Tampa, FL – March 16th , 2022, Leading wound care management
How Denial Management Can Boost Financial Stability for Clinics
How Denial Management Can Boost Financial Stability for Clinics Denial management is one of the most crucial aspects of revenue cycle management (RCM) for healthcare
WoundGenex and Shoreline Medical Administration Form Strategic Alliance to Deliver Bundled Revenue Cycle Solutions with Clawback Protection
WoundGenex and Shoreline Medical Administration Form Strategic Alliance to Deliver Bundled Revenue Cycle Solutions with Clawback Protection TAMPA, Fla., Sept. 2, 2025 /PRNewswire/ — WoundGenex, the industry
The LCD Delay — Victory or Wake-Up Call?
On the surface, the recent delay of the new Medicare LCD for skin substitutes to January 2026 may appear to be a win for providers and patients alike. After all, the proposed LCDs raised numerous concerns around access, frequency limits, and clinical documentation requirements.